Sonendo, Inc. (SONX)

USD 1.15

(-14.81%)

Total Liabilities Summary of Sonendo, Inc.

  • Sonendo, Inc.'s latest annual total liabilities in 2023 was 49.74 Million USD , down -10.1% from previous year.
  • Sonendo, Inc.'s latest quarterly total liabilities in 2024 Q2 was 28.43 Million USD , down -11.82% from previous quarter.
  • Sonendo, Inc. reported annual total liabilities of 55.33 Million USD in 2022, up 27.38% from previous year.
  • Sonendo, Inc. reported annual total liabilities of 43.43 Million USD in 2021, down -86.84% from previous year.
  • Sonendo, Inc. reported quarterly total liabilities of 32.24 Million USD for 2024 Q1, down -35.18% from previous quarter.
  • Sonendo, Inc. reported quarterly total liabilities of 49.74 Million USD for 2023 FY, down -10.1% from previous quarter.

Annual Total Liabilities Chart of Sonendo, Inc. (2023 - 2019)

Historical Annual Total Liabilities of Sonendo, Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 49.74 Million USD -10.1%
2022 55.33 Million USD 27.38%
2021 43.43 Million USD -86.84%
2020 330.03 Million USD 0.51%
2019 328.36 Million USD 0.0%

Peer Total Liabilities Comparison of Sonendo, Inc.

Name Total Liabilities Total Liabilities Difference
Acutus Medical, Inc. 54.83 Million USD 9.296%
Biotricity, Inc. 35.91 Million USD -38.479%
Cell MedX Corp. 872.57 Thousand USD -5600.471%
Dynatronics Corporation 11.78 Million USD -322.245%
Nemaura Medical Inc. 26.37 Million USD -88.574%
PetVivo Holdings, Inc. 2.42 Million USD -1947.545%
RetinalGenix Technologies Inc. 1.4 Million USD -3438.237%
Telesis Bio, Inc. 40.87 Million USD -21.696%
Talis Biomedical Corporation 29.22 Million USD -70.206%
Viveve Medical, Inc. 10.84 Million USD -358.569%